News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Goldman Sachs: tech hiring slowed about 5 percentage points yearly since 2022, mainly due to post‑pandemic overhiring rather than rates or AI.
  • Israeli airstrike in Gaza City killed at least two people amid stalled ceasefire talks, raising regional tensions.
  • Israel's cabinet voted to ignore a Supreme Court ruling on the broadcast regulator, risking constitutional crisis and regulatory uncertainty.
  • easyJet accepted Castlelake's GBP6.90 per share takeover offer valuing the airline at GBP5.23bn, resolving a drawn‑out bid process.
  • Rivian raised its 2026 delivery guide to 65,000–70,000 after 12,194 Q2 deliveries, supporting delivery momentum and investor interest.
  • President Trump will hold bilateral talks at the NATO summit, including meetings with Ukraine and Syria leaders to discuss conflict resolution.

Latest Articles

Ligand Shares Slide After $550M Convertible Note Offering Announced

Ligand Shares Slide After $550M Convertible Note Offering Announced

Ligand Pharmaceuticals shares fell in pre-market trading following the firm's disclosure of a private placement of $550 million in convertible senior notes due September 2031, with an underwriter option for an additional $82.5 million. The debt issuance, structured as a Rule 144A offering to qualified institutional buyers, raises both leverage and …

ITG Seeks $2.67 Billion Valuation in Nasdaq IPO

ITG Seeks $2.67 Billion Valuation in Nasdaq IPO

ITG, a Tennessee-based provider of outsourced digital infrastructure services, filed to list on the Nasdaq and aims to raise up to $429.3 million by offering 19.5 million Class A common shares at a $19 to $22 price range. At the top of that range, the offering would imply a $2.67 billion valuation. The company and a selling stockholder are providin…

Alan Greenspan, Former Federal Reserve Chair, Dies at 100

Alan Greenspan, Former Federal Reserve Chair, Dies at 100

Alan Greenspan, who led the U.S. Federal Reserve for 18.5 years after being appointed by President Ronald Reagan, died on June 22, 2026, at age 100 from complications of Parkinson’s Disease. His wife, NBC News journalist Andrea Mitchell, confirmed his passing and reflected on his public role and private life. Greenspan's tenure encompassed major ma…

Lime Files for U.S. IPO Aiming for Up to $1.66 Billion Valuation

Lime Files for U.S. IPO Aiming for Up to $1.66 Billion Valuation

Lime, the San Francisco-based electric bike and scooter rental company backed by Uber, has filed for a U.S. initial public offering that could value the business at as much as $1.66 billion. The company and certain selling shareholders intend to offer roughly 6.96 million shares at a proposed range of $24 to $26 per share, with Lime selling the vas…

Ambiq Micro Shares Slip After S-1 Reveals Potentially Dilutive Offering

Ambiq Micro Shares Slip After S-1 Reveals Potentially Dilutive Offering

Ambiq Micro's stock fell in pre-market trade after the company filed a Form S-1 registration statement disclosing an underwritten public offering that could increase the share count meaningfully. The filing, dated June 22, 2026, outlines up to 1,800,000 new shares with an underwriters' overallotment option that could bring the total to 2,070,000 sh…

Cheap, Cash-Flowing Auto Parts Play: Why SMP Deserves a Buy Ticket

Cheap, Cash-Flowing Auto Parts Play: Why SMP Deserves a Buy Ticket

Standard Motor Products (SMP) looks inexpensive relative to its cash generation and recent acquisition-driven growth. Q1 2026 revenue of $451.2M (up 9.1% YoY), adjusted EBITDA of $44.5M and free cash flow of roughly $39.4M underpin a durable payout, an elevated dividend yield near 3.3% and an EV/EBITDA of ~8.2. For investors willing to accept modes…

Vicor: The Under-the-Radar AI Power Compounder

Vicor: The Under-the-Radar AI Power Compounder

Vicor makes high-density modular power systems that are suddenly mission-critical for AI datacenters. Strong Q1 results, a $301M backlog, and capacity expansion give near-term revenue visibility; the stock trades rich, but a controlled swing trade captures ongoing enterprise demand with clear stops and targets.

Castor Maritime Inc. Announces Vessel Acquisition

Castor Maritime Inc. Announces Vessel Acquisition

Castor Maritime Inc., a NASDAQ-listed diversified global shipping and energy company, announced the agreement to acquire a modern 2023-built eco-friendly Kamsarmax bulk carrier for $37.5 million. The vessel acquisition, expected to close by the end of the quarter, will expand the company's fleet to 10 vessels, enhancing its dry bulk shipping capaci…

Bernstein Raises Targets for Memory Leaders as HBM Prices Poised to Climb

Bernstein Raises Targets for Memory Leaders as HBM Prices Poised to Climb

Bernstein has increased its price targets for Samsung Electronics, SK Hynix and Micron Technology, citing an expected substantial rise in high-bandwidth memory (HBM) prices. The broker warns that higher HBM and other memory costs could push hyperscaler data center capital expenditures up by as much as 30%, while leaving KIOXIA unchanged under an Un…

TSX Futures Flat as Gold Rally Offsets Drop in Oil Ahead of May CPI

TSX Futures Flat as Gold Rally Offsets Drop in Oil Ahead of May CPI

Toronto stock-index futures were essentially unchanged as falling crude prices were balanced by a rebound in gold, while attention turns to the upcoming Consumer Price Index reading for May. The underlying S&P/TSX Composite finished a volatile week with a modest decline, and markets are watching core inflation metrics which could influence Bank of …

Buy Insmed on TPIP Phase 3 Momentum and Re-Rate Opportunity

Buy Insmed on TPIP Phase 3 Momentum and Re-Rate Opportunity

Insmed (INSM) is a commercial-stage rare-disease biopharma with a deep TPIP (Treprostinil Palmitil Inhalation Powder) Phase 3 program. The stock has pulled back to $95.77 after a stretch of volatility, trading well off its $212.75 52-week high. Given the market cap of roughly $20.7B, solid liquidity metrics, and an active short base, we view the cu…

Quantum Cyber Issues Letter to Shareholders

Quantum Cyber Issues Letter to Shareholders

Quantum Cyber N.V. updates shareholders on recent strategic developments including high-level engagements with U.S. government officials, a defense and military conference, progress toward acquiring a Connecticut manufacturing facility for drone production, and improved financial strength with over $15 million raised from warrant exercises, positio…

Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds

Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds

Nuvectis Pharma has entered an exclusive licensing agreement with Haisco Pharmaceutical Group to acquire ex-China rights to two late-stage clinical compounds: NXP100, a once-daily oral Complement Factor B inhibitor targeting complement-mediated diseases including PNH, IgAN, and LN; and NXP200, a paradox-breaker BRAF inhibitor for BRAF-mutated malig…

SL Green Realty Corp. to Release Second Quarter 2026 Financial Results After Market Close on July 22, 2026

SL Green Realty Corp. to Release Second Quarter 2026 Financial Results After Market Close on July 22, 2026

SL Green Realty Corp., Manhattan's largest office landlord and a leading REIT, will release its financial results for the second quarter of 2026 after market close on July 22, 2026. The company will host a conference call and webcast on July 23, 2026 to discuss these results, with supplemental financial data made available concurrently on its websi…

FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations

FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations

Palvella Therapeutics announced that the FDA has granted rolling review for its New Drug Application (NDA) for QTORIN™ rapamycin, aimed at treating microcystic lymphatic malformations, a rare and serious skin disease with no existing FDA-approved therapies. The company expects to complete NDA submission in late 2026, leveraging FDA designations to …

Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

Medicus Pharma Ltd., a Nasdaq-listed biotech company, announced its participation in the 2026 Bio International Conference to present advancements in its clinical development programs for SkinJect®, an innovative treatment for basal cell carcinoma and Gorlin Syndrome, and Teverelix®, a next-generation GnRH antagonist targeting prostate cancer, acut…